Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. LICENSE AGREEMENTLicense Agreement • January 18th, 2007 • Cougar Biotechnology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 18th, 2007 Company Industry JurisdictionThis AGREEMENT is made by and between BTG INTERNATIONAL LTD., a British corporation with its principal place of business at 10 Fleet Place, Limeburner Lane, London, EC4M 7SB, England (“BTG”); and COUGAR BIOTECHNOLOGY INC., a Delaware Corporation with its principal place of business in Los Angeles, California, USA (“Licensee”).
Portions herein identified by [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. LICENSE AGREEMENTLicense Agreement • December 21st, 2006 • Cougar Biotechnology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 21st, 2006 Company Industry JurisdictionThis AGREEMENT is made by and between BTG INTERNATIONAL LTD., a British corporation with its principal place of business at 10 Fleet Place, Limeburner Lane, London, EC4M 7SB, England (“BTG”); and COUGAR BIOTECHNOLOGY INC., a Delaware Corporation with its principal place of business in Los Angeles, California, USA (“Licensee”).